The FDA has approved the first over-the-counter continuous blood glucose monitor, the Stelo Glucose Biosensor System by Dexcom. It will be available in the US this summer for people over 18 who do not use insulin to treat their diabetes. The device allows individuals to monitor their blood glucose levels continuously without the need for frequent finger pricks. This new technology will provide greater convenience for managing diabetes and improve overall quality of life for those using it.
Source link
FDA approves first over-the-counter blood glucose monitor for diabetes
